Peer Review History
| Original SubmissionNovember 9, 2020 |
|---|
|
Dear Dr. Werts, Thank you very much for submitting your manuscript "Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Brian Stevenson, Ph.D. Associate Editor PLOS Neglected Tropical Diseases Richard Phillips Deputy Editor PLOS Neglected Tropical Diseases *********************** Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: The methods are fully described and are appropriate for addressing the overall study objective. Reviewer #2: Study design, sample size, methods employed and statistical analyses are adequate. Reviewer #3: -The objective of the study was clearly stated: To assess the long-term antibody response (in mice) and protection against subsequent infection with various Leptopspira strains. -Yes, the appropriate concentration of bacteria was used for infection experiments and standardized laboratory methodologies were used to measure bacterial loads and antibodies, RT-PCR and ELISA, respectively. -The mouse model is the appropriate system since infection of mice with Leptospira is not fatal, allowing long-term measurement of the antibody response. -The sample size and statistics used to measure differences could use some clarification in the methodology. -No ethical or regulatory concerns. -------------------- Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: Overall the results are clear and well presented. Comments on the results section are relatively minor: 1. Lines 336-338 and discussion: to understand the significance of the differing response to the infectious dose, the authors should indicate, if known, the expected dose during a natural infection. 2. Figure 3B, left panel: why did two previously infected mice have a higher leptospiral organ burden? Was there a different immune response detected in these two outlier mice? Reviewer #2: Results, figures and tables are clearly presented. Reviewer #3: -Yes -Yes -Yes -------------------- Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: There appears to be a disconnect between the findings shown in Figure 1A and Figure 3A, in that the avirulent serovars provided a minimal humoral response but still protected the mice from subsequent homologous infection. On Line 647-650 the authors offer an explanation for a similar result obtained with heat-killed Manilae; do the authors expect cell-mediated immunity also plays a role in the observed immunity with the avirulent serovars? Reviewer #2: Conclusions are supported by the data presented. Discussion covers comparison and how this study is important. Reviewer #3: -The conclusions are supported by the data. -The limitations of the study could be better communicated. -Yes. -Relevance to public health was addressed but not directly. -------------------- Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: 1. Lines 191 and 421: to conform with standard nomenclature for animal experimentation, it is recommended that the word “killed” be replaced with “euthanized”. 2. Figure 3A: it is recommended that the Y axis be expanded to decrease the clustering of the data points, and to increase the ability to view these data points, especially at the early time periods. Reviewer #2: (No Response) Reviewer #3: I did not catch any errors, I would say the authors are more than capable of polishing the text as needed. -------------------- Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: The manuscript “Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization” by Vernel-Pauillac et. al. reports on the differing immunological response of mice infected with 3 different serovars of Leptospira to advance the understanding of the correlates of protection against disease. Overall this manuscript provides an important contribution to the Leptospira field of study and provides insight relevant to vaccine development. Reviewer #2: This manuscript by Vernel-Pauillac et al provides some interesting information about immune responses in C57BL/6J mice to different strains leptospires belonging to three serovars. Different immunoglobulin types/subtypes were measured over a period of time. Mice were challenged with homologous bacteria. This study is important in understanding immune responses to leptospiral infection and may have implications on improving diagnostics. Here are some questions/comments: 1. Since the main focus of the study is measuring immunoglobulin types/subtypes, more information is needed on the ELISA used in this study, eg., (i) was this assay developed/validated in-house? Please provide a reference(s) in either case. (ii) is there any known cross-reactivity among different anti-mouse antibodies used in this study? Please provide a reference if available. 2. Is it possible that the observed relationship between persistent peripheral IgM levels and renal colonization has something to do with the immune environment of kidneys and this phenomenon has some similarity to immune deviation seen during infection of sites like brain, eyes, testes etc.? -------------------- PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Azad Eshghi Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods |
| Revision 1 |
|
Dear Dr. Werts, We are pleased to inform you that your manuscript 'Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Brian Stevenson, Ph.D. Associate Editor PLOS Neglected Tropical Diseases Richard Phillips Deputy Editor PLOS Neglected Tropical Diseases *********************************************************** |
| Formally Accepted |
|
Dear Dr. Werts, We are delighted to inform you that your manuscript, "Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .